| IBBQ | 12.19% | 22.01 | -1.61% | 215,732 | |
| VRTX | 7.93% | 468.85 | -2.23% | 5,825 | |
| AMGN | 7.08% | 295.27 | -1.70% | 9,073 | |
| GILD | 6.89% | 109.64 | -4.28% | 24,451 | |
| REGN | 5.76% | 567.74 | +1.43% | 3,747 | |
| AZN | 3.94% | 71.13 | -0.95% | 20,296 | |
| ALNY | 3.14% | 314.94 | -2.39% | 4,512 | |
| ARGX | 1.90% | 560.24 | -0.54% | 1,116 | |
| BIIB | 1.66% | 134.21 | -0.83% | 5,102 | |
| SMMT | 1.64% | 25.000 | -3.40% | 25,711 |
Mirae Asset TIGER NASDAQ Bio ETF is an exchange traded fund launched and managed by Mirae Asset Investments Co., Ltd. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of companies across all market capitalizations with a minimum market capitalization of $200 million. It seeks to replicate the performance of the NASDAQ Biotechnology Index (Price Return), by investing in stocks of companies as per their weightings in the Index. Mirae Asset TIGER NASDAQ Bio ETF was formed on August 27, 2014 and is domiciled in South Korea.